Glyoxal‑induced disruption of tumor cell progression in breast cancer
Molecular and Clinical Oncology · 15.02.2023 · 18 (4)
DOI: 10.3892/mco.2023.2622 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular and Clinical Oncology, online erschienen am 15.02.2023. Verfasst von Pu Rong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Chengdu Fuxing Hospital, Chengdu, Sichuan 610037, P.R. China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Chengdu Fuxing Hospital, Chengdu, Sichuan 610037, P.R. China.
- Department of Research, Chengdu Fuxing Hospital, Chengdu, Sichuan 610037, P.R. China.
- Department of Head and Neck Oncology, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Zitieren
APA
Rong, P., Yanchu, L., Nianchun, G., Qi, L., & Xianyong, L. (2023). Glyoxal‑induced disruption of tumor cell progression in breast cancer. Molecular and Clinical Oncology, 18(4). https://doi.org/10.3892/mco.2023.2622
Vancouver
Rong P, Yanchu L, Nianchun G, Qi L, Xianyong L. Glyoxal‑induced disruption of tumor cell progression in breast cancer. Molecular and Clinical Oncology. 2023;18(4). doi:10.3892/mco.2023.2622
BibTeX
@article{Rong2023,
author = {Rong, Pu and Yanchu, Li and Nianchun, Guo and Qi, Li and Xianyong, Li},
title = {Glyoxal‑induced disruption of tumor cell progression in breast cancer},
journal = {Molecular and Clinical Oncology},
year = {2023},
volume = {18},
number = {4},
doi = {10.3892/mco.2023.2622}
}
EUVIMED